These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20833867)

  • 1. Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study.
    Gonzalez-Perez A; Schlienger RG; Rodríguez LA
    Diabetes Care; 2010 Dec; 33(12):2580-5. PubMed ID: 20833867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study.
    Giorda CB; Picariello R; Nada E; Tartaglino B; Marafetti L; Costa G; Gnavi R
    Lancet Diabetes Endocrinol; 2014 Feb; 2(2):111-5. PubMed ID: 24622714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.
    Lai SW; Muo CH; Liao KF; Sung FC; Chen PC
    Am J Gastroenterol; 2011 Sep; 106(9):1697-704. PubMed ID: 21577242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
    Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
    Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
    Liao KF; Lin CL; Lai SW; Chen WC
    Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study.
    Chang CH; Lin JW; Chen ST; Lai MS; Chuang LM; Chang YC
    Medicine (Baltimore); 2016 Feb; 95(7):e2603. PubMed ID: 26886601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
    Knapen LM; de Jong RG; Driessen JH; Keulemans YC; van Erp NP; De Bruin ML; Leufkens HG; Croes S; de Vries F
    Diabetes Obes Metab; 2017 Mar; 19(3):401-411. PubMed ID: 27883260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of acute pancreatitis in patients with type 2 diabetes: an observational study using a Japanese hospital database.
    Urushihara H; Taketsuna M; Liu Y; Oda E; Nakamura M; Nishiuma S; Maeda R
    PLoS One; 2012; 7(12):e53224. PubMed ID: 23300896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
    Koro CE; Bowlin SJ; Weiss SR
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
    Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of severe acute pancreatitis in patients with diabetes.
    Shen HN; Chang YH; Chen HF; Lu CL; Li CY
    Diabet Med; 2012 Nov; 29(11):1419-24. PubMed ID: 22506974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan.
    Tseng CH
    Ann Med; 2015; 47(7):561-9. PubMed ID: 26426676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis.
    Blomgren KB; Sundström A; Steineck G; Wiholm BE
    Diabetes Care; 2002 Feb; 25(2):298-302. PubMed ID: 11815499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.
    Kollhorst B; Behr S; Enders D; Dippel FW; Theobald K; Garbe E
    Diabetes Obes Metab; 2015 Dec; 17(12):1158-65. PubMed ID: 26279482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.
    Soranna D; Bosetti C; Casula M; Tragni E; Catapano AL; Vecchia CL; Merlino L; Corrao G
    Diabetes Res Clin Pract; 2015 May; 108(2):243-9. PubMed ID: 25748827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.
    Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT
    Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC; Quilliam BJ
    Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
    Brodovicz KG; Kou TD; Alexander CM; O'Neill EA; Engel SS; Girman CJ; Goldstein BJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1123-8. PubMed ID: 22831166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.
    Maru S; Koch GG; Stender M; Clark D; Gibowski L; Petri H; White AD; Simpson RJ
    Diabetes Care; 2005 Jan; 28(1):20-6. PubMed ID: 15616228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.